Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides

Biological Chemistry

Volumn 388, Issue 4, 2007, Pages 447-455

  Barros, Nilana M T ^a   Campos, Marcelo ^a   Bersanetti, Patrícia A ^a   Oliveira, Vitor ^a   Juliano, Maria A ^a   Boileau, Guy ^b   Juliano, Luiz ^a   Carmona, Adriana K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin hydrolysis; Carboxydipeptidase; Continuous assay; FRET substrates; NEP; Neprilysin

Indexed keywords

AMINO ACID; BRADYKININ; CARRIER PROTEIN; ETHYLENEDIAMINE DERIVATIVE; FLUORESCENT DYE; MEMBRANE METALLOENDOPEPTIDASE; PEPTIDE DERIVATIVE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME SPECIFICITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYDROLYSIS; HYDROPHOBICITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

2,4-DINITROPHENOL; ANIMALS; ANTHRANILIC ACIDS; BRADYKININ; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYDROGEN-ION CONCENTRATION; KIDNEY; LUNG; MALE; METHYLTRANSFERASES; NEPRILYSIN; OLIGOPEPTIDES; RATS; SODIUM CHLORIDE; SUBSTRATE SPECIFICITY;

EID: 34047142654     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.048     Document Type: Article

References (48)

1. Araujo, M.C., Melo, R.L., Cesari, M.H.S., Juliano, M.A., Juliano, L., and Carmona, A.K. (2000). Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39, 8519-8525.
2. Barany, G. and Merrifield, R.B. (1980). The Peptides: Analysis, Synthesis and Biology, Vol. 2, E. Gross and J. Meienhofer, eds. (New York, USA: Academic Press), pp. 1-284.
3. Bateman, R.C. Jr., Jackson D., Slaughter, C.A., Unnithan, S., Chai, Y.G., Moomaw, C., and Hersh, L.B. (1989). Identification of the active-site arginine in rat neutral endopeptidase 24.11 (enkephalinase) as arginine 102 and analysis of a glutamine 102 mutant. J. Biol. Chem. 264, 6151-6157.
4. Beaumont, A., Le Moual, H., Boileau, G., Crine, P., and Roques, B.P. (1991). Evidence that both arginine 102 and arginine 747 are involved in substrate binding to neutral endopeptidase (EC 3.4.24.11). J. Biol. Chem. 266, 214-220.
5. Bradford, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Carvalho, K.M., Boileau, G., França, M.S.F., Camargo, A.C.M., and Juliano, L. (1995). A new fluorimetric assay for neutral endopeptidase (EC 3.4.24.11.). Braz. J. Med. Biol. Res. 28, 1055-1059.
7. Chagas, J.R., Juliano, L., and Prado, E.S. (1990). Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins. Anal. Biochem. 192, 419-425.
8. Cushman, D.W. and Cheung, H.S. (1971). Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim. Biophys. Acta 250, 261-265.
9. Dion, N., Le Moual, H., Fournié-Zaluski, M.C., Roques, B.P., Crine, P., and Boileau, G. (1995). Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2' residue of substrates and inhibitors. Biochem. J. 311, 623-627.
10. 2' subsite. FEBS Lett. 411, 140-144.
11. Fields, G.B. and Noble, R.L. (1990). Solid-phase peptide-synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161-214.
12. Florentin, D., Sassi, A., and Roques, B.P. (1984). A highly sensitive fluorometric assay for 'enkephalinase', a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal. Biochem. 141, 62-69.
13. Fossiez, F., Lemay, G., Labonte, N., Parmentier-Lesage, F., Boileau, G., and Crine, P. (1992). Secretion of a functional form of neutral endopeptidase 24:11 from a baculovirus-infected cell line. Biochem. J. 284, 53-59.
14. Gafford, J.T., Skidgel, R.A., Erdos, E.G., and Hersh, L.B. (1983). Human kidney 'enkephalinase', a neutral metalloendopeptidase that cleaves active peptides Biochemistry 22, 3265-3271.
15. 2)Phe-βAla, a specific fluorogenic substrate for neutral endopeptidase 24.11. Anal. Biochem. 219, 87-95.
16. Groisman, G.M. and Meir, A. (2003). CD10 is helpful in detecting occult or inconspicuous endometrial stromal cells in cases of presumptive endometriosis. Arch. Pathol. Lab. Med. 127, 1003-1006.
17. Hersh, L.B. and Morihara, K. (1986). Comparison of the subsite specificity of the mammalian neutral endopeptidase 24-11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. J. Biol. Chem. 261, 6433-6437.
18. Hirata, I.Y., Cesari, M.H.S., Nakaie, C.R., Boshcov, P., Ito, A.S., Juliano, M.A., and Juliano, L. (1994). Internally quenched fluorogenic protease substrates: solid-phase synthesis and fluorescent spectroscopy of peptides containing ortho-aminobenzoyl-dinitrophenyl groups as donor-acceptor pairs. Lett. Pept. Sci. 1, 299-301.
19. Hooper, N.M. (1994). Families of zinc metalloproteases. FEBS Lett. 354, 1-6.
20. Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N.P., Gerard, C., Hama, E., Lee, H.J., and Saido, T.C. (2001). Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552.
21. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Seikiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.J., Hama, E., Sekine-Aizawa, Y., and Saido, T.C. (2000). Identification of the major Aβ1-42 degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
22. Kerr, M.A. and Kenny, A.J. (1974). The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem. J. 137, 477-488.
23. Kim, Y.-A., Shriver, B., Quay, T., and Hersh, L.B. (1992). Analysis of the importance of arginine 102 in neutral endopeptidase (enkephalinase) catalysis. J. Biol. Chem. 17, 12330-12335.
24. Leatherbarrow, R.J. (1992). Grafit Version 3.0 (Staines, UK: Erithacus Software Ltd.).
25. Lemay, G., Waksman, G., Roques, B.P., Crine, P., and Boileau, G. (1989). Fusion of a cleavable signal peptide to the ectodomain of neutral endopeptidase (EC 3.4.24.11) results in the secretion of an active enzyme in COS-1 cells. J. Biol. Chem. 264, 15620-15623.
26. Letarte, M., Vera, S., Tran, R., Addis, J.B., Onizuka, R.J., Quackenbush, E.J., Jongeneel, C.V., and McInnes, R.R. (1988). Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 168, 1247-1253.
27. Malfroy, B. and Schwartz, J.C. (1982). Properties of enkephalinase from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem. Biophys. Res. Commun. 106, 276-285.
28. Malfroy, B. and Burnier, J. (1987). New substrates for enkephalinase (neutral endopeptidase) based on fluorescence energy transfer. Biochem. Biophys. Res. Commun. 143, 58-66.
29. Malfroy, B. and Schwartz, J.C. (1985). Comparison of dipeptidyl carboxypeptidase and endopeptidase activities in the three enkephalin- hydrolysing metallopeptidases: 'angiotensin-converting enzyme', thermolysin and 'enkephalinase'. Biochem. Biophys. Res. Commun. 130, 372-378.
30. Matsas, R., Fulcher, I.S., Kenny, A.J., and Turner, A.J. (1983). Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. Natl. Acad. Sci. USA 80, 3111-3115.
31. Matsas, R., Kenny, A.J., and Turner, A.J. (1984). The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem. J. 223, 433-440.
32. Medeiros, M.A.S., Franca, M.S.F., Boileau, G., Juliano, L., and Carvalho, K.M. (1997). Specific fluorogenic substrates for neprylysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases. Braz. J. Med. Biol. Res. 30, 1157-1162.
33. Molinaro, G., Rouleau, J.L., and Adam, A. (2002). Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics. Curr. Opin. Pharmacol. 2, 131-141.
34. Oefner, C., D'Arcy, A., Hennig, M., Winkler, F.K., and Dale, G.E. (2000). Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J. Mol. Biol. 296, 341-349.
35. Ottesen, B., Gerstenberg, T., Ulrichsen, H., Manthorpe, T., Fahrenkrug, J., and Wagner, G. (1983). Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits uterine smooth muscle activity in women. Eur. J. Clin. Invest. 13, 321-324.
36. Pryde, D.C., Maw, G.N., Planken, S., Platts, M.Y., Sanderson, V., Corless, M., Stobie, A., Barber, C.G., Russell, R., Foster, L., et al. (2006). Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides. J. Med. Chem. 13, 4409-4424.
37. Quay, T., Slaughter, C., Davis, T.P., Merril, B.J., and Hersh, L.B. (1994). Positional effects in the neprilysin (neutral endopeptidase) reaction. Arch. Biochem. Biophys. 308, 133-136.
38. Ramírez-Molina, C., Heudi, O., Pullen, M., and Marshall, P.S. (2006). Study of bradykinin metabolism by rat lung tissue membranes and rat kidney brush border membranes by HPLC with inductively coupled plasma-mass spectrometry orthogonal acceleration time-of-flight mass spectrometry. J. Pept. Sci. 12, 220-226.
39. Relton, J.M., Gee, N.S., Matsas, R., Turner, A.J., and Kenny, A.J. (1983). Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem. J. 215, 519-523.
40. Ronco, P., Pollard, H., Galceran, M., Delauche, M., Schwartz, J.C., and Verroust. P. (1988). Distribution of enkephalinase (membrane metalloendopeptidase, EC 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab. Invest. 58, 210-217.
41. Roques, B.P., Noble, F., Dauge, V., Fournie-Zaluski, M.C., and Beaumont, A. (1993). Neutral Endopeptidase 24.11: structure, inhibition and experimental and clinical pharmacology. Pharmacol. Rev. 45, 87-146.
42. Schechter, I. and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
43. Schwartz, J.C., Malfroy, G., and De La Baume, S. (1981). Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl- carboxypeptidase ('enkephalinase') as neuropeptidase. Life Sci. 29, 1715-1740.
44. Skidgel, R.A. (1992). Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. J. Cardiovasc. Pharmacol. 9, 4-9.
45. Turner, A.J. and Tanzawa, K. (1997). Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11, 355-364.
46. Turner, A.J., Matsas, R., and Kenny, A.J. (1985). Are there neuropeptide-specific peptidases? Biochem. Pharmacol. 34, 1347-1356.
47. Welsch, C., Grima, M., Giesen, E.M., Helwig, J.J., Barthelmebs, M., Coquard, C., and Imbs, J.L. (1989). Assay of tissue angiotensin converting enzyme. J. Cardiovasc. Pharmacol. 4, S26-S31.
48. Whitworth, J.A. (2003). Emerging drugs in the management of hypertension. Expert Opin. Emerg. Drugs 8, 377-388.